CLPT
ClearPoint Neuro, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.17
+1.10%Year over year
Reported trailing growth
- Revenue
- +25.9%
- EBITDA
- -31.4%
- EBIT
- -37.2%
- EPS
- -45.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +30.0%
- EBITDA
- +1.8%
- EPS
- -2.1%
Three-year CAGR
- Revenue
- +21.6%
- EBITDA
- -22.6%
- EBIT
- -22.4%
- Net income
- -35.0%
- EPS
- -28.6%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026